Within the pharmaceutical, biotechnology, and regulatory sectors, CRL can refer to two distinct and prominent terms. In corporate financial markets and ticker listings, it stands for Charles River Laboratories, a premier global contract research organization. In regulatory affairs governed by the United States Food and Drug Administration, it stands for Complete Response Letter, an official communication sent to a drug sponsor detailing why a new drug application cannot be approved in its current form.